| TOPOTECAN |
Topotecan Accord® |
Accord Healthcare |
Advanced metastatic ovarian cancer |
Jul 2020 |
Recommended |
| TERBUTALINE |
Bricanyl®Turbuhaler® |
AstraZeneca Pty Ltd |
Bronchospasm |
Jul 2020 |
Recommended |
| VITAMINS, MINERALS AND TRACE ELEMENTS WITH CARBOHYDRATE |
Paediatric Seravit® |
Nutricia Australia Pty Ltd |
Dietary management of conditions requiring a highly restrictive therapeutic diet |
Jul 2020 |
Recommended |
| CARBOHYDRATE, FAT, VITAMINS, MINERALS AND TRACE ELEMENTS |
Energivit® |
Nutricia Australia Pty Ltd |
Proven inborn errors of protein metabolism |
Jul 2020 |
Recommended |
| BROLUCIZUMAB |
Beovu® |
Novartis Pharmaceuticals Australia Pty Ltd |
Subfoveal choroidal neovascularisation (CNV) |
Jul 2020 |
Not Recommended |
| GLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS |
Tylactin Build 20® |
Cortex Health Pty Ltd |
Tyrosinaemia |
Jul 2020 |
Recommended |
| EPINEPHRINE |
Symjepi® |
Emerge Health Pty Ltd |
Acute allergic reactions including anaphylaxis |
Jul 2020 |
Deferred |
| BELIMUMAB |
Benlysta® |
GlaxoSmithKline Australia Pty Ltd |
Systemic lupus erythemosus (SLE) |
Jul 2020 |
Not Recommended |
| CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX |
Dysport® |
Ipsen Pty Ltd |
Focal spasticity of the upper limb |
Jul 2020 |
Recommended |
| DOLUTEGRAVIR WITH LAMIVUDINE |
Dovato® |
ViiV Healthcare Australia Pty Ltd |
Human immunodeficiency virus (HIV) infection |
Jul 2020 |
Recommended |
| ACALABRUTINIB |
Calquence® |
AstraZeneca Pty Ltd |
Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) |
Jul 2020 |
Not Recommended |
| SIPONIMOD |
Mayzent® |
Novartis Pharmaceuticals Australia Pty Ltd |
Multiple sclerosis (MS) |
Jul 2020 |
Recommended |
| OSIMERTINIB |
Tagrisso® |
AstraZeneca Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Jul 2020 |
Recommended |
| RIVAROXABAN |
Xarelto® |
Bayer Australia Pty Ltd |
Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) |
Jul 2020 |
Recommended |
| RAVULIZUMAB |
Ultomiris® |
Alexion Pharmaceuticals Australasia Pty Ltd |
Paroxysmal nocturnal haemoglobinuria (PNH) |
Jul 2020 |
Not Recommended |
| TIOTROPIUM WITH OLODATEROL |
Spiolto Respimat® |
Boehringer Ingelheim Pty Ltd |
Chronic obstructive pulmonary disease (COPD) |
Jul 2020 |
Recommended |
| VENETOCLAX |
Venclexta® |
AbbVie Pty Ltd |
Chronic lymphocytic leukaemia (CLL) |
Jul 2020 |
Recommended |
| TAFAMIDIS |
Vyndamax® |
Pfizer Australia Pty Ltd |
Transthyretin amyloid cardiomyopathy (ATTR-CM) |
Jul 2020 |
Not Recommended |
| PARACETAMOL |
Panadol® |
Glaxosmithkline Australia Pty Ltd |
Palliative care |
Jul 2020 |
Recommended |
| AMINO ACID FORMULA WITH CARBOHYDRATE, VITAMINS, MINERALS AND TRACE ELEMENTS WITHOUT
PHENYLALANINE, SUPPLEMENTED WITH DOCOSAHEXAENOIC ACID |
PKU Synergy® |
Nutricia Australia Pty Ltd |
Phenylketonuria (PKU) |
Jul 2020 |
Not Recommended |
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT VALINE, LEUCINE AND ISOLEUCINE |
MSUD Lophlex® |
Nutricia Australia Pty Ltd |
Maple Syrup Urine Disease (MSUD) |
Jul 2020 |
Recommended |
| NUSINERSEN |
Spinraza® |
Biogen Australia Pty Ltd |
Spinal muscular atrophy (SMA) |
Jul 2020 |
Recommended |
| MILK POWDER SYNTHETIC LOW CALCIUM |
Locasol® |
Nutricia Australia Pty Ltd |
Hypercalcaemia |
Jul 2020 |
Recommended |
| INDACATEROL WITH MOMETASONE |
Atectura Breezhaler® |
Novartis Pharmaceuticals Australia Pty Ltd |
Asthma |
Jul 2020 |
Recommended |
| ARMODAFINIL & MODAFINIL |
Various brands |
Australasian Sleep Association |
Narcolepsy |
Jul 2020 |
Deferred |
| PROTEIN FORMULA WITH VITAMINS AND MINERALS, LOW IN POTASSIUM, PHOSPHORUS, CALCIUM,
CHLORIDE AND VITAMIN A |
Renastep® |
Vitaflo Australia Pty Ltd |
Dietary management of children with chronic renal failure from 3-18 years of age |
Jul 2020 |
Recommended |
| RIBOCICLIB |
Kisqali® |
Novartis Pharmaceuticals Australia Pty Ltd |
Breast cancer |
Jul 2020 |
Deferred |
| APREMILAST |
Otezla® |
Amgen Australia Pty Ltd |
Plaque psoriasis |
Jul 2020 |
Recommended |
| BECLOMETASONE DIPROPIONATE + FORMOTEROL FUMARATE DIHYDRATE |
Fostair® |
Emerge Health Pty Ltd |
Asthma |
Jul 2020 |
Recommended |
| ADALIMUMAB |
Hadlima® |
Merck, Sharp & Dohme (Australia) Pty Ltd |
Severe active rheumatoid arthritis; Severe psoriatic arthritis; Ankylosing spondylitis;
Severe chronic plaque psoriasis; Juvenile idiopathic arthritis; Severe crohn’s disease;
Refractory fistulising crohn’s disease; moderate to severe hidradenitis suppurativa |
Jul 2020 |
Recommended |
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE AND TYROSINE |
TYR Lophlex® |
Nutricia Australia Pty Ltd |
Tyrosinaemia (TYR) |
Jul 2020 |
Recommended |
| SACUBITRIL/VALSARTAN |
Entresto® |
Novartis Pharmaceuticals Australia Pty Ltd |
Chronic heart failure |
Jul 2020 |
Not Applicable |
| DULAGLUTIDE |
Trulicity® |
Eli Lilly Australia Pty Ltd |
Type 2 Diabetes Mellitus (T2DM) |
Jul 2020 |
Recommended |
| FOSNETUPITANT (AS CHLORIDE HYDROCHLORIDE)/PALONOSETRON (AS HYDROCHLORIDE) |
AKYNZEO IV® |
Mundipharma Pty Limited |
Nausea and vomiting |
Jul 2020 |
Recommended |
| GUSELKUMAB |
Tremfya® |
Janssen-Cilag Pty Ltd |
Severe chronic plaque psoriasis |
Jul 2020 |
Recommended |
| DARATUMUMAB |
Darzalex® |
Janssen-Cilag Pty Ltd |
Multiple myeloma |
Jul 2020 |
Recommended |
| TRIGLYCERIDES MEDIUM CHAIN FORMULA |
Monogen® |
Nutricia Australia Pty Ltd |
Dietary management of conditions requiring a source of medium chain triglycerides,
hyperlipoproteinaemia type 1, long chain fatty acid oxidation disorders, chlyous ascites
and chylothorax |
Jul 2020 |
Recommended |
| WHEY PROTEIN FORMULA SUPPLEMENTED WITH AMINO ACIDS, VITAMINS AND MINERALS, AND LOW
IN PROTEIN, PHOSPHATE, POTASSIUM AND LACTOSE |
Kindergen® |
Nutricia Australia Pty Ltd |
Chronic Renal Failure (CRF) |
Jul 2020 |
Recommended |
| TIOTROPIUM |
Spiriva Respimat® |
Boehringer Ingelheim Pty Ltd |
Bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (COPD);
severe asthma |
Jul 2020 |
Recommended |
| CARFILZOMIB |
Kyprolis® |
Amgen Australia Pty Ltd |
Multiple myeloma |
Jul 2020 |
Recommended |
| CANNABIDIOL |
Epidyolex® |
Emerge Health Pty Ltd |
Lennox-Gastaut syndrome Dravet syndrome |
Jul 2020 |
Deferred |
| BEVACIZUMAB |
Zirabev® |
Pfizer Australia Pty Ltd |
Advanced International Federation of Gynecology and Obstetrics (FIGO) Stage IIIB,
IIIC or Stage IV epithelial ovarian, fallopian tube or primary peritoneal cancer;
Advanced carcinoma of cervix; Relapsed or recurrent glioblastoma; Stage IV (metastatic)
non-small cell lung cancer (NSCLC); Metastatic colorectal cancer. |
Jul 2020 |
Recommended |
| OCRELIZUMAB |
Ocrevus® |
Roche Products Pty Ltd |
Primary progressive multiple sclerosis (PPMS) |
Jul 2020 |
Not Recommended |
| MOGAMULIZUMAB |
Poteligeo® |
Kyowa Kirin Australia Pty Ltd |
Cutaneous T-Cell Lymphoma (CTCL) |
Jul 2020 |
Not Recommended |
| IXEKIZUMAB |
Taltz® |
Eli Lilly Australia Pty Ltd |
Ankylosing spondylitis |
Jul 2020 |
Recommended |
| ATEZOLIZUMAB + BEVACIZUMAB |
Tecentriq®; Avastin® |
Roche Products Pty Ltd |
Hepatocellular carcinoma (HCC) |
Jul 2020 |
Recommended |
| LANADELUMAB |
Takhzyro® |
Shire Australia Pty Ltd |
Hereditary angioedema |
Jul 2020 |
Deferred |
| AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT METHIONINE |
HCU Lophlex® |
Nutricia Australia Pty Ltd |
Pyridoxine non-responsive homocystinuria |
Jul 2020 |
Recommended |
| AMINO ACID FORMULA WITH VITAMINS, MINERALS AND LONG CHAIN POLYUNSATURATED FATTY ACIDS
WITHOUT PHENYLALANINE; AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE
AND TYROSINE; AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW
IN TRYPTOPHAN; AMINO ACID FORMULA WITH VITAMINS AND MMMINERALS WITHOUT METHIONINE,
THREONINE AND VALINE AND LOW IN ISOLEUCIINE; AMINO ACID FORMULA WITH VITAMINS AND
MINERALS WITHOUT VALINE, LEUCINE AND ISOLEUCINE |
Anamix Infant® Formulas |
Nutricia Australia Pty Ltd |
Phenylketonuria (PKU); Tyrosinaemia (TYR); Glutaric Aciduria Type 1; Methylmalonic
acidaemia and Propionic acidaemia; Proven pyridoxine non-responsive homocystinuria;
Proven maple syrup urine disease |
Jul 2020 |
Recommended |
| OLAPARIB |
Lynparza® |
AstraZeneca Pty Ltd |
Ovarian, fallopian tube or primary peritoneal cancer |
Jul 2020 |
Recommended |
| NIVOLUMAB IPILIMUMAB |
Opdivo®; Yervoy® |
Bristol-Myers Squibb Australia Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Jul 2020 |
Not Recommended |
| FULVESTRANT |
Faslodex® |
AstraZeneca Pty Ltd |
Breast cancer |
Jul 2020 |
Recommended |
| ENOXAPARIN |
Enoxapo® |
Apotex Pty Ltd |
Prevention and treatment of deep vein thrombosis; haemodialysis |
Jul 2020 |
Recommended |
| DAROLUTAMIDE |
Nubeqa® |
Bayer Australia Pty Ltd |
Prostate cancer |
Jul 2020 |
Not Recommended |
| INDACATEROL WITH GLYCOPYRRONIUM AND MOMETASONE |
Enerzair Breezhaler® |
Novartis Pharmaceuticals Australia Pty Ltd |
Asthma |
Jul 2020 |
Deferred |
| CATIONIC OPTHALMIC EMULSION, PRESERVATIVE FREE |
Cationorm® |
Seqiris (Australia) Pty Ltd |
Severe dry eye syndrome |
Jul 2020 |
Recommended |
| CAPLACIZUMAB |
Cablivi® |
Sanofi-Aventis Australia Pty Ltd |
Acquired thrombotic thrombocytopenic purpura |
Jul 2020 |
Not Recommended |
| BIMATOPROST |
Vizo-PF Bimatoprost® |
AFT Pharmaceuticals Pty Ltd |
Reduction of elevated intraocular pressure or open angle glaucoma, as first line therapy
or monotherapy or as adjunctive therapy to topical beta-blockers. |
Jul 2020 |
Recommended |
| RIFAMPICIN |
Rimycin 150®; Rimycin 300® |
Mylan |
For the treatment of mycobacterium ulcerans infections (Buruli ulcer) |
Jul 2020 |
Deferred |
| SELEXIPAG |
Uptravi® |
Janssen-Cilag Pty Ltd |
Pulmonary arterial hypertension (PAH) |
Jul 2020 |
Recommended |
